Evfm sec
WebApr 11, 2024 · A high-level overview of Evofem Biosciences, Inc. (EVFM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebAug 4, 2024 · Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended June 30, 2024 and affirmed full-year 2024 guidance.
Evfm sec
Did you know?
WebEvofem Biosciences Inc. (EVFM) sec form 4 filings insider trading, insiders stock buying and selling. WebMar 10, 2024 · SAN DIEGO, March 3, 2024 - Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the …
WebDec 31, 2024 · The aggregate market value of the common stock held by non‑affiliates of the registrant was approximately $ 172,915,009 as of June 30, 2024, based upon the … WebFind the latest Evofem Biosciences, Inc. (EVFM) stock quote, history, news and other vital information to help you with your stock trading and investing.
WebUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15 (d) … WebEvofem Clocks 42% Growth For Its On-Demand Birth Control Product. Evofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting …
WebApr 10, 2024 · 0001618835 2024-04-05 2024-04-05 iso4217:USD xbrli:shares iso4217:USD
WebAug 10, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 8-K Corporate News Accession Number: 0001618835-22-000158 Submitted to the SEC: Wed Aug 10 2024 8:52:21 AM EST Accepted by the SEC: Wed Aug 10 2024 Period: Tuesday, August 9, 2024 Industry: Pharmaceutical Preparations Events: Listing Status; External Resources: Stock Quote … chandnish ahluwalia md incWebEvofem Biosciences Inc. SEC filings breakout by MarketWatch. View the EVFM U.S. Securities and Exchange Commission reporting information. harbourside group of companiesWebMar 31, 2024 · As of March 31, 2024, the Baker Notes are recorded in the condensed consolidated balance sheet as short-term convertible notes payable with a total balance of $ 53.2 million. The balance is comprised of a $ 50.9 million fair value of the Baker Notes and $ 2.3 million in accrued interest. chandni sharma instagramWebView the EVFM U.S. Securities and Exchange Commission reporting information. Evofem Biosciences Inc. SEC filings breakout by MarketWatch. Skip to main content Main Menu harbourside gynaecology centre poole hospitalWebAug 12, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 10-Q Quarterly Report Accession Number: 0001618835-22-000166 Submitted to the SEC: Fri Aug 12 2024 5:22:31 PM EST Accepted by the SEC: Fri Aug 12 2024 Period: Thursday, June 30, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark … chandni shethWebFeb 15, 2024 · Ticker: EVFM CIK: 1618835 Form Type: Proxy Statements Form DEF 14A Accession Number: 0001618835-23-000008 Submitted to the SEC: Wed Feb 15 2024 4:00:21 PM EST Accepted by the SEC: Wed Feb 15 2024 Period: Wednesday, March 15, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social … harbourside glass and maintenanceWebEVFM Profile. Company Profile. Evofem Biosciences Inc. 12400 High Bluff Drive. ... Alexander A. Fitzpatrick General Counsel and Secretary: Derivative/Non-derivative $0.86 PER SHARE: 42,120 $36,223 ... harbourside gluten free plymouth